Richard Kaiser
On June 17, 2026, the Company’s Board of Directors appointed Richard Kaiser as the Company’s interim Chief Executive Officer.
Highest-materiality recent filing
Bioforce receives Ryder Scott prospective resources report for Nevada oil and gas leases
Ryder Scott report covers ~19,957 acres in White River Valley, Nye County, Nevada, as of July 1, 2026.
BioForce NanoSciences appoints interim CEO, adds director and advisory board members
Richard Kaiser appointed interim CEO on June 17, 2026; he remains CFO, Secretary, and Director.
Bioforce Nanosciences receives BLM approval for 11 oil & gas leases on ~19,957 acres in Nevada
BLM approved assignment of 11 federal oil and gas leases covering ~19,957 acres in White River Valley, Nye County, Nevada.
Received assignment of 11 federal oil & gas leases covering ~19,957 acres in Nye County, Nevada, from majority-shareholder-controlled Natural Minerals Trust; BLM approval pending.
BioForce Nanosciences changes control; sells 79.65% stake; pivots to oil & gas
Merle Ferguson sold 26.7M shares (79.65% of outstanding) to Nexus Capital Investments for $400,000 on April 15, 2026.
BioForce Nanosciences replaces auditor BF Borgers with Michael Gillespie & Associates
Effective May 7, 2024, BioForce Nanosciences dismissed BF Borgers CPA PC as its independent auditor and retained Michael Gillespie & Associates, PLLC.
BioForce Nanosciences appoints Co-CEOs and President, CEO Merle Ferguson resigns
CEO & President Merle Ferguson resigned Nov 30, 2021; remains Chairman, no dispute with company.
On June 17, 2026, the Company’s Board of Directors appointed Richard Kaiser as the Company’s interim Chief Executive Officer.
On June 17, 2026, the Company’s Board of Directors received resignation letters from Mr. Steven Gagnon and Mr. John LaViolette as BioForce Nanosciences Holdings, Inc.’s Co-Chief Executive Officers (CEOs), and from Sasha Shapiro the Company’s Vice-President.
Effective June 15, 2026, the Board of Directors appointed Scott Mager as Directors of the Company.
On June 17, 2026, the Company’s Board of Directors received resignation letters from Mr. Steven Gagnon and Mr. John LaViolette as BioForce Nanosciences Holdings, Inc.’s Co-Chief Executive Officers (CEOs), and from Sasha Shapiro the Company’s Vice-President.
On June 17, 2026, the Company’s Board of Directors received resignation letters from Mr. Steven Gagnon and Mr. John LaViolette as BioForce Nanosciences Holdings, Inc.’s Co-Chief Executive Officers (CEOs), and from Sasha Shapiro the Company’s Vice-President.
the Board of Directors accepted the resignation of Mr. Merle Ferguson as Chief Executive Officer and President, effective November 30, 2021.
appointed both Mr. Steve Gagnon and Mr. John LaViolette as Co-Chief Executive Officers (Co-CEOs), effective November 30, 2021.
appointed Sasha Shapiro as President, effective November 30, 2021.
appointed both Mr. Steve Gagnon and Mr. John LaViolette as Co-Chief Executive Officers (Co-CEOs), effective November 30, 2021.
Max materiality 0.90 · Median 0.55 · Most common event other_material